These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
484 related items for PubMed ID: 12907605
1. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Song K, Cornelius SC, Danielpour D. Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605 [Abstract] [Full Text] [Related]
2. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB. Cancer Res; 1994 Jul 01; 54(13):3413-21. PubMed ID: 8012960 [Abstract] [Full Text] [Related]
3. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells. Tang B, de Castro K, Barnes HE, Parks WT, Stewart L, Böttinger EP, Danielpour D, Wakefield LM. Cancer Res; 1999 Oct 01; 59(19):4834-42. PubMed ID: 10519393 [Abstract] [Full Text] [Related]
4. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines. Salm SN, Koikawa Y, Ogilvie V, Tsujimura A, Coetzee S, Moscatelli D, Moore E, Lepor H, Shapiro E, Sun TT, Wilson EL. J Cell Physiol; 2000 Jul 01; 184(1):70-9. PubMed ID: 10825235 [Abstract] [Full Text] [Related]
5. Transforming growth factor beta 1 in liver carcinogenesis: messenger RNA expression and growth effects. Braun L, Gruppuso P, Mikumo R, Fausto N. Cell Growth Differ; 1990 Mar 01; 1(3):103-11. PubMed ID: 1964076 [Abstract] [Full Text] [Related]
6. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis. Guo Y, Kyprianou N. Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572 [Abstract] [Full Text] [Related]
7. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637 [Abstract] [Full Text] [Related]
8. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Gao J, Arnold JT, Isaacs JT. Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338 [Abstract] [Full Text] [Related]
9. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F, Strand DW, Rowley DR. Oncogene; 2008 Jan 17; 27(4):450-9. PubMed ID: 17637743 [Abstract] [Full Text] [Related]
10. Restoration of transforming growth factor-beta type II receptor reduces tumorigenicity in the human adrenocortical carcinoma SW-13 cell line. Yamamoto N, Imai J, Watanabe M, Hiroi N, Sugano S, Yoshino G. Horm Metab Res; 2006 Mar 17; 38(3):159-66. PubMed ID: 16673206 [Abstract] [Full Text] [Related]
11. Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Hayward SW, Wang Y, Cao M, Hom YK, Zhang B, Grossfeld GD, Sudilovsky D, Cunha GR. Cancer Res; 2001 Nov 15; 61(22):8135-42. PubMed ID: 11719442 [Abstract] [Full Text] [Related]
12. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells. Danielpour D. J Cell Physiol; 1996 Jan 15; 166(1):231-9. PubMed ID: 8557772 [Abstract] [Full Text] [Related]
13. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Okamoto M, Oyasu R. Cell Growth Differ; 1997 Aug 15; 8(8):921-6. PubMed ID: 9269901 [Abstract] [Full Text] [Related]
14. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK. Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532 [Abstract] [Full Text] [Related]
15. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Sheng H, Shao J, O'Mahony CA, Lamps L, Albo D, Isakson PC, Berger DH, DuBois RN, Beauchamp RD. Oncogene; 1999 Jan 28; 18(4):855-67. PubMed ID: 10023661 [Abstract] [Full Text] [Related]
16. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid. De Benedetti F, Falk L, Ruscetti FW, Colburn NH, Faltynek CR, Oppenheim JJ. Cancer Res; 1991 Feb 15; 51(4):1158-64. PubMed ID: 1847657 [Abstract] [Full Text] [Related]
17. Altered growth regulation and loss of response to retinoic acid accompany tumorigenic transformation of prostatic cells. Peehl DM, Sellers RG, Arnstein P, Kung HF, Rhim JS. Anticancer Res; 1999 Feb 15; 19(5B):3857-64. PubMed ID: 10628324 [Abstract] [Full Text] [Related]
18. A novel human cancer culture model for the study of prostate cancer. Yasunaga Y, Nakamura K, Ko D, Srivastava S, Moul JW, Sesterhenn IA, McLeod DG, Rhim JS. Oncogene; 2001 Nov 29; 20(55):8036-41. PubMed ID: 11753687 [Abstract] [Full Text] [Related]
19. Regulation of transforming growth factor beta receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Zhao J, Buick RN. Cancer Res; 1995 Dec 15; 55(24):6181-8. PubMed ID: 8521411 [Abstract] [Full Text] [Related]
20. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Chen A, Davis BH, Sitrin MD, Brasitus TA, Bissonnette M. Am J Physiol Gastrointest Liver Physiol; 2002 Oct 15; 283(4):G864-74. PubMed ID: 12223346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]